🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06578611
Starting soon Observational

Perioperative Smoking Cessation in Elderly Chinese Undergoing Spinal Fusion

NCT06578611 · tracked via the Priya Life Science China tracker
Sponsor
The Second Hospital of Shandong University
Phase
Observational
Started
2024-09
Last updated
2024-08-29

Condition(s) studied

Spinal Fusion

Investigational drug(s) / intervention(s)

Enhanced recovery after surgery

Enhanced recovery after surgery: Recommended pre-, intra-, and post-operative care interventions in the enhanced recovery after surgery.

Study summary

As China's society ages faster, the number of elderly patients undergoing spinal fusion surgery will gradually increase. Since elderly patients are at higher risk of postoperative complications than younger patients, minimizing complications after spinal fusion becomes a priority in postoperative rehabilitation. The purpose of this prospective cohort study is to develop an enhanced recovery after surgery program including individualized perioperative smoking cessation strategies in Chinese elderly undergoing spinal fusion.

Eligibility

Sex
ALL
Min age
65 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Patients aged 65 years old or more; 2. Patients who plan to undergo spinal fusion with ERAS program; 3. Patients who agreed to participate in this study. Exclusion Criteria: 1. Patients who cannot understand the study content or have difficulty communicating; 2. Patients with a history of spinal fusion surgery; 3. Patients with spinal fractures, spinal tumor, or spinal infections; 4. Patients with congenital spinal deformity; 5. Patients who were unable to complete at least 6 months of follow-up; 6. Patients with incomplete clinical information.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The Second Hospital of Shandong University Jinan Shandong

More The Second Hospital of Shandong University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06578611 on ClinicalTrials.gov ↗ ← All trials in China